Startup Treeline Bio Emerges From the Shadows With $1B+ Raised and 3 Cancer Drugs in the Clinic
Eschewing the traditional model of financing biotech startups milestone to milestone to support a lead asset, Treeline Biosciences’ well-funded pipeline is comprised of multiple complementary programs. Select investors have supported the approach of Treeline, which said it has raised more than $1.1 billion to date.
NewDays Secures $7M To Expand Treatment for Cognitive Impairment, Dementia
NewDays' $7 million seed round was led by General Catalyst and Madrona. The funds will be used to expand into additional states and grow its team.
What One Investor Believes Is the Key to Healthcare AI Success
Chirag Shah, partner at Define Ventures, thinks the success of a healthcare AI startup often depends on its ability to move beyond a narrow point solution. By integrating AI into workflows and expanding from initial “wedges” into full platforms, startups can stand out from the competition, he said.
Caught Between Visits: How Our System Fails People With Parkinson’s and Dementia
Much of today’s care infrastructure was built for a different era, when medicine focused on acute illnesses and short-term fixes. But neurodegenerative diseases don’t follow that script, and neither can we. We have the tools to build something better: care that stays with people, adapts to their needs, and helps them live not just longer, but better.
Easing Frontline Pressure: How AI Can Lift the Administrative Burden Off Care Teams
AI agents excel in operating within compliance frameworks, offloading structured tasks while escalating edge cases to human providers. They show great promise in helping reclaim clinical capacity and reduce the mounting administration associated with modern medicine.